相关实验视频

Updated: Jun 11, 2026

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

各种基因型的染性细胞瘤和副质瘤中的转移性疾病 - 一个系统的审查和元分析

Louise Kirkegaard Svendsen¹, Åse Krogh Rasmussen¹, Marianne Christina Klose¹

¹Department of Nephrology and Endocrinology, Copenhagen University Hospital: Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.

The Journal of clinical endocrinology and metabolism

|November 3, 2025

概括

携带遗传变异的超结瘤和染细胞瘤 (PPGL) 患者患转移性疾病的风险更高. 这项研究发现,与没有病原性生殖系变异的PPGL患者相比,PPGL患者的转移率增加.

科学领域:

在瘤学瘤学.
遗传学遗传学是一个
内分泌学在内分泌学.

背景情况:

帕拉格林瘤和发红细胞瘤 (PPGLs) 是一种罕见的神经内分泌瘤.
10-20%的PPGL患者会发生转移性疾病.
PPGLs具有很高的遗传性,与转移相关的遗传变异.

研究的目的:

调查PPGL患者基因型与转移性疾病风险之间的关联.
在基因型转移风险分析中调整时间.

主要方法:

在PubMed和Embase的系统文献搜索.
分析以确定每100个患者年中转移性疾病的发生率.
超回归分析用于比较变体组.

主要成果:

致病性生殖系变体显著增加了转移性疾病的发病率,与未识别的变体相比 (1.55/100患者年).
特定变异 (SDHA,SDHC,SDHD,VHL,RET,NF1,MAX,EPAS1) 显示出不同的转移率.
超回归表明SDHB变异的发病率比其他集群1变异高出2.3倍.

结论:

基因型与PPGL患者转移性疾病风险有关.
患有致病性遗传变异的患者的转移率更高.
高异质性需要进一步的大型队列研究.

关键词:

抛售者可能会变得更强大.基因型基因型基因型进行元分析分析.转移转移转移转移叶染色细胞瘤 ( pheochromocytoma) 是一种致血性细胞瘤.系统性审查系统性审查

更多相关视频

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...